Pharmacy Friends

In this special edition of Pharmacy Friends, Mostafa Kamal, Prime Therapeutics, President and CEO, joined Capital Rx’s Chief Executive Officer AJ Loiacono and SVP of Marketing & Communications Michael Passanante on the Astonishing Healthcare Podcast by Capital Rx.

They share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy and provide better care to patients across the country leveraging next-generation technology: JUDI®. 

Prime's Newsroom

www.primetherapeutics.com

All Pharmacy Friends episodes

Capital Rx podcasts

https://www.cap-rx.com/

Welcome to Pharmacy Friends – we bring industry experts to

A hot topic in the health care industry is GLP1s and chronic weight management. In this last segment of our two-part episode, our experts discuss Prime’s analysis of real-world integrated pharmacy and medical claims data. 

Hosting today’s episode “The Skinny on GLP1s,” is Maryam

The Skinny on GLP-1s: Part 1

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year

All Pharmacy Friends episodes

https://www.primetherapeutics.com/

 A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.  

Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.   

These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines. 

Check out our other GLP1 content

David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year

More about Prime

News and information

In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it’s impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered. 

Newsroom - https://www.primetherapeutics.com/news/

Making pharmacy’s future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/

Join Prime - https://www.primetherapeutics.com/careers/

Discover how the brightest minds in oncology are illuminating the possibilities. Listen to Simone Ndujiuba, Oncology Clinical Strategy, and Innovation Director, and Dr. Joseph Leach Chief Medical Officer at Prime Therapeutics and Medical Oncologist at the University of Minnesota Physicians, join forces to discuss next-generation trends, cutting-edge technologies, and their captivating journey of becoming oncologists.

*Prime Therapeutics does not practice medicine.

Hosted by Brian MacDonald, director of specialty clinical strategy at Prime, and joined by Kourteney Martinez, pharmacy engagement specialist at Blue Cross Blue Shield of Alabama.

Jonathan Magness, vice president of Medicare Part D operations sits down with Mark Santilli, senior director of clinical strategy and programs, to talk managed care, the future of pharmacy, and more!

Jonathan Magness, vice president of Medicare Part D operations sits down with Alaka'i Montalbo, senior manager of formulary management, to talk managed care, the future of pharmacy, and more!

The field of oncology is rapidly changing and evolving, with treatment becoming more precise and the speed of innovation compounding each year.

As more targeted therapies come to market, more patients have the hope of living a longer life. In this past record-setting year, more novel cancer medicines became available for the first time than in any year in history, and many of them employ immunology or precision biomarkers to transform the way patients are treated.

On this episode of Pharmacy Friends, we’re diving deep into precision medicine with Haita Makanji, Vice President of Clinical Strategy and Innovation at Prime, and Clynt Taylor, President of Trapelo. Trapelo offers the first, interoperable, decision-support platform used by oncologists, labs, and payers to inform testing and treatment, streamline workflow and facilitate real-time alignment in precision medicine.

Listen and learn how precision medicine be maximized to give cancer patients the best possible outcomes.

This episode is brought to you by the Prime Specialty Summit. After two years of virtual events, we're back in New York City, bringing you brilliant speakers, thought-provoking panels, in-person networking, and live music. Register now.

Millions of Americans are diagnosed with Type 2 diabetes, a serious and expensive health condition.

In this episode of Pharmacy Friends, Prime Medical Director, Dr. Marci Chodroff, moderates an engaging discussion on all things diabetes and the key to improving patient health and reducing healthcare costs. Joining Dr. Chodroff is Barb Corn, Vice President of Physician and Clinical Operations, and Dr. Arpeta Gupta, endocrinologist expert and Magellan Rx Physician Clinical Reviewer. 

If you would like to learn more about the CDC National Diabetes Prevention Program, check out these resources: